Skip to main content
. 2021 Aug 13;30(5):48–54. [Article in German] doi: 10.1007/s15007-021-4847-0
Impfstoff, Hersteller Inhaltsstoffe Status
BNT162b2 (Comirnaty®), Pfizer/BioNTech

mRNA ALC-0315 ((4-hydroxybutyl)azanediyl)bis (hexane-6,1-diyl)bis(2-hexyldecanoate) ALC-0159 (2-[(polyethylene glycol)-2000]- N,N-ditetradecylacetamide 1,2-Distearoyl-sn-glycero-3-phophocholine

Cholesterol Kaliumchlorid, Kaliumdihydrogenphosphat, Natriumchlorid, Dinatriumhydrogenphosphat-dihydrat, Saccharose Durchstechflasche: Naturlatex-Stopfen

Post-EUA
mRNA-1273 (Moderna®), Moderna Biotech mRNA SM (sphyngomyelin)-102 Polyethylenglycol [PEG] 2000 dimyristoyl glycerol [DMG] 1,2-distearoyl-sn-glycero-3-phosphocholine [DPSC] Cholesterol Tromethamin-Hydrochlorid, Essigsäure, Natriumacetat, Saccharose Post-EUA
AZD1222 (Vaxzevria®/ AstraZeneca), AstraZeneca modifizierter Virus (ChAdOx1 nCoV-19) Polysorbat 80 = Polyoxyethylen-20-sorbitanmonooleat Histine, Saccharose, Natriumchlorid, Magnesiumchlorid NatriumEDTA, Ethanol Post-EU
Ad26.COV2.S (Janssen), Johnson & Johnson

Adenivirus26 vectored vaccine Natriumchlorid, Zitronensäure-monohydrat Polysorbat 80 = Polyoxyethylen-20-sorbitanmonooleat

2 hydroxylpropyl-B-cyclodextrin (HBCD)

Ethanol, Natriumhydroxid

Post-EU
NVX-CoV2373, Novavax Rec. SARS-CoV-2 glycoprotein nanoparticle mit MatrixM adjuvant Polysorbat 80 = Polyoxyethylen-20-sorbitanmonooleat Matrix M1 adjuvant Phase III
EU, Europäische Union; EUA, emergency use authorization; mRNA, messenger-RNA